Wallace, Kedra <br/><br/>
Novel treatment avenues for uterine leiomyoma: a new implication for endothelin?  [electronic resource] 

 -  Clinical science (London, England : 1979)  10 2018 
 - 2261-2267 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1470-8736 
<br/><br/><label>Standard No.: </label>10.1042/CS20180474  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cells, Cultured<br/>Cysteine-Rich Protein 61--metabolism<br/>Endothelin A Receptor Antagonists--pharmacology<br/>Female<br/>Humans<br/>Hysterectomy--methods<br/>Leiomyoma--metabolism<br/>Myocytes, Smooth Muscle--drug effects<br/>Myometrium--metabolism<br/>Oxygen--metabolism<br/>Receptor, Endothelin A--metabolism<br/>Uterine Neoplasms--metabolism